Epimedin B ameliorates benzo[a]pyrene -induced C2C12 myotube atrophy through p53 signaling pathway

Mengling Ma, Minyi Zheng, Xiangnan Qin, Kefei Xiao, Zhangbin Gong

Open source

DOI
10.1016/j.cellsig.2026.112906
Published
2026-09
Container
Cellular Signalling
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cellsig.2026.112906,
  title = {Epimedin B ameliorates benzo[a]pyrene -induced C2C12 myotube atrophy through p53 signaling pathway},
  author = {Mengling Ma and Minyi Zheng and Xiangnan Qin and Kefei Xiao and Zhangbin Gong},
  year = {2026},
  journal = {Cellular Signalling},
  doi = {10.1016/j.cellsig.2026.112906},
  url = {https://doi.org/10.1016/j.cellsig.2026.112906}
}

RIS

TY  - JOUR
TI  - Epimedin B ameliorates benzo[a]pyrene -induced C2C12 myotube atrophy through p53 signaling pathway
AU  - Mengling Ma
AU  - Minyi Zheng
AU  - Xiangnan Qin
AU  - Kefei Xiao
AU  - Zhangbin Gong
PY  - 2026
JO  - Cellular Signalling
DO  - 10.1016/j.cellsig.2026.112906
UR  - https://doi.org/10.1016/j.cellsig.2026.112906
ER  - 

APA

Ma, M., Zheng, M., Qin, X., Xiao, K., & Gong, Z. (2026). Epimedin B ameliorates benzo[a]pyrene -induced C2C12 myotube atrophy through p53 signaling pathway. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112906

Source records